Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody

Lignende værker

• Systemic immunotherapy of superficial mouse bladder cancer with Avelumab (MSB0010718C), an anti-PD-L1 immune checkpoint inhibitor
  af: Vandeveer, Amanda, et al.
  Udgivet: (2015)
• Systemic Immunotherapy of Non–Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor
  af: Vandeveer, Amanda J., et al.
  Udgivet: (2016)
• Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab
  af: Fujii, Rika, et al.
  Udgivet: (2016)
• ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody
  af: Jochems, Caroline, et al.
  Udgivet: (2017)
• Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody
  af: Nagaya, Tadanobu, et al.
  Udgivet: (2016)